You are here

  • Home
  • Archive
  • Volume 12, Issue Suppl 1
  • P06.01 Gain-of-function CARD11 signalling in B cells causes pathological lymphoproliferative disease in mice which is strictly dependent on MALT1 activity

Article info

Article menu

Download PDFPDF

Poster Presentations
06. B cells in IO
P06.01 Gain-of-function CARD11 signalling in B cells causes pathological lymphoproliferative disease in mice which is strictly dependent on MALT1 activity

Authors

  • A Kratzert TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • E Morrish TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • SJ Keppler TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • J Ruland TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany PubMed articlesGoogle scholar articles

Citation

Kratzert A, Morrish E, Keppler S, et al
P06.01 Gain-of-function CARD11 signalling in B cells causes pathological lymphoproliferative disease in mice which is strictly dependent on MALT1 activity
Journal for ImmunoTherapy of Cancer 2024;12:doi: 10.1136/jitc-2024-ITOC10.42
Online issue publication 
March 20, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.